Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Electroconvulsive Therapy | 21 | 2024 | 506 | 3.550 |
Why?
|
Delirium | 9 | 2022 | 1707 | 2.530 |
Why?
|
Natural Language Processing | 16 | 2022 | 1203 | 2.420 |
Why?
|
Electronic Health Records | 33 | 2024 | 4873 | 2.420 |
Why?
|
Restraint, Physical | 3 | 2024 | 186 | 2.300 |
Why?
|
Nursing Staff, Hospital | 4 | 2024 | 350 | 1.640 |
Why?
|
Hospitalization | 27 | 2024 | 10808 | 1.390 |
Why?
|
Hospitals, General | 4 | 2023 | 802 | 1.350 |
Why?
|
Depressive Disorder, Major | 18 | 2024 | 4808 | 1.340 |
Why?
|
Mental Disorders | 7 | 2024 | 6851 | 1.120 |
Why?
|
Inpatients | 9 | 2024 | 2564 | 1.080 |
Why?
|
Computer Security | 2 | 2018 | 261 | 1.050 |
Why?
|
Patient Readmission | 9 | 2021 | 3286 | 1.000 |
Why?
|
Patient Discharge | 9 | 2023 | 3461 | 0.930 |
Why?
|
Psychopathology | 4 | 2024 | 435 | 0.920 |
Why?
|
Confidentiality | 2 | 2018 | 607 | 0.910 |
Why?
|
Cytochrome P-450 Enzyme System | 2 | 2017 | 423 | 0.900 |
Why?
|
Prader-Willi Syndrome | 1 | 2024 | 77 | 0.880 |
Why?
|
Academic Medical Centers | 7 | 2022 | 2780 | 0.830 |
Why?
|
Ilizarov Technique | 2 | 2012 | 13 | 0.820 |
Why?
|
Length of Stay | 10 | 2024 | 6485 | 0.690 |
Why?
|
Ethics Consultation | 4 | 2022 | 59 | 0.690 |
Why?
|
Drug Discovery | 2 | 2019 | 1064 | 0.640 |
Why?
|
Hyperkalemia | 1 | 2021 | 233 | 0.640 |
Why?
|
Genetic Loci | 2 | 2019 | 2631 | 0.630 |
Why?
|
Emergency Services, Psychiatric | 1 | 2019 | 65 | 0.620 |
Why?
|
Narration | 3 | 2021 | 223 | 0.600 |
Why?
|
Humans | 159 | 2025 | 765956 | 0.580 |
Why?
|
Demography | 4 | 2023 | 1641 | 0.570 |
Why?
|
Receptors, Formyl Peptide | 1 | 2018 | 146 | 0.570 |
Why?
|
Nurse's Role | 1 | 2019 | 187 | 0.560 |
Why?
|
Genome-Wide Association Study | 5 | 2024 | 12807 | 0.550 |
Why?
|
Behavioral Symptoms | 1 | 2019 | 187 | 0.550 |
Why?
|
Diagnostic Self Evaluation | 1 | 2019 | 228 | 0.540 |
Why?
|
Consumer Health Information | 1 | 2019 | 215 | 0.540 |
Why?
|
Patient Admission | 3 | 2021 | 1365 | 0.530 |
Why?
|
Suicide | 2 | 2019 | 1604 | 0.530 |
Why?
|
Hospital Departments | 1 | 2017 | 135 | 0.530 |
Why?
|
Risk Assessment | 17 | 2024 | 24283 | 0.530 |
Why?
|
Hospitals | 8 | 2023 | 3888 | 0.520 |
Why?
|
Cation Transport Proteins | 1 | 2019 | 325 | 0.520 |
Why?
|
Retrospective Studies | 59 | 2024 | 81515 | 0.510 |
Why?
|
Female | 100 | 2025 | 396101 | 0.510 |
Why?
|
Catatonia | 3 | 2024 | 181 | 0.510 |
Why?
|
Databases, Factual | 3 | 2024 | 8067 | 0.510 |
Why?
|
Premature Birth | 3 | 2023 | 1829 | 0.500 |
Why?
|
Accidents | 1 | 2016 | 164 | 0.490 |
Why?
|
Psychotic Disorders | 4 | 2023 | 3268 | 0.490 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 3 | 2020 | 1989 | 0.490 |
Why?
|
Biological Specimen Banks | 2 | 2019 | 786 | 0.480 |
Why?
|
Nuclear Family | 1 | 2016 | 311 | 0.480 |
Why?
|
Bibliometrics | 1 | 2018 | 357 | 0.480 |
Why?
|
Mood Disorders | 2 | 2021 | 1128 | 0.470 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 1514 | 0.470 |
Why?
|
Early Diagnosis | 1 | 2020 | 1187 | 0.470 |
Why?
|
Obstetrics | 1 | 2021 | 680 | 0.460 |
Why?
|
Cohort Studies | 29 | 2024 | 41647 | 0.460 |
Why?
|
Central Nervous System Agents | 1 | 2015 | 72 | 0.460 |
Why?
|
Death | 1 | 2019 | 686 | 0.450 |
Why?
|
Male | 84 | 2025 | 363691 | 0.450 |
Why?
|
Education, Nursing, Continuing | 1 | 2014 | 68 | 0.440 |
Why?
|
Psychotropic Drugs | 1 | 2019 | 879 | 0.440 |
Why?
|
Middle Aged | 62 | 2025 | 223004 | 0.430 |
Why?
|
Adult | 75 | 2025 | 223038 | 0.420 |
Why?
|
Object Attachment | 1 | 2016 | 329 | 0.420 |
Why?
|
Accidental Falls | 4 | 2024 | 1078 | 0.420 |
Why?
|
Interleukins | 1 | 2018 | 791 | 0.420 |
Why?
|
Drug Interactions | 1 | 2017 | 1417 | 0.400 |
Why?
|
United States | 23 | 2024 | 72898 | 0.400 |
Why?
|
Drug Repositioning | 1 | 2015 | 246 | 0.400 |
Why?
|
Arthroplasty, Replacement, Ankle | 1 | 2012 | 26 | 0.400 |
Why?
|
Nurses | 1 | 2022 | 2505 | 0.400 |
Why?
|
Leg Length Inequality | 1 | 2012 | 57 | 0.390 |
Why?
|
Fetal Death | 1 | 2014 | 435 | 0.390 |
Why?
|
Genetic Predisposition to Disease | 4 | 2019 | 18071 | 0.390 |
Why?
|
Health Education | 1 | 2019 | 1060 | 0.390 |
Why?
|
Central Nervous System | 1 | 2019 | 1341 | 0.390 |
Why?
|
Arousal | 1 | 2018 | 1171 | 0.390 |
Why?
|
Massachusetts | 11 | 2024 | 8871 | 0.380 |
Why?
|
Insurance Claim Review | 1 | 2016 | 745 | 0.380 |
Why?
|
Diabetes Complications | 1 | 2018 | 1316 | 0.370 |
Why?
|
Medical Informatics | 1 | 2018 | 745 | 0.370 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2015 | 497 | 0.370 |
Why?
|
Models, Statistical | 5 | 2021 | 5089 | 0.360 |
Why?
|
Databases, Genetic | 1 | 2018 | 1751 | 0.360 |
Why?
|
Aged | 50 | 2024 | 171114 | 0.360 |
Why?
|
Arthrodesis | 1 | 2012 | 186 | 0.360 |
Why?
|
Forecasting | 3 | 2019 | 2936 | 0.360 |
Why?
|
Antidepressive Agents | 8 | 2024 | 2897 | 0.340 |
Why?
|
Evidence-Based Practice | 1 | 2014 | 500 | 0.330 |
Why?
|
Hospital Mortality | 7 | 2021 | 5343 | 0.330 |
Why?
|
Job Satisfaction | 3 | 2022 | 548 | 0.330 |
Why?
|
Psychiatry | 5 | 2020 | 1714 | 0.330 |
Why?
|
Internet | 3 | 2019 | 3106 | 0.320 |
Why?
|
Schizophrenia | 4 | 2024 | 6971 | 0.320 |
Why?
|
Limb Salvage | 1 | 2012 | 488 | 0.320 |
Why?
|
Arm | 1 | 2012 | 589 | 0.320 |
Why?
|
Logistic Models | 12 | 2024 | 13266 | 0.320 |
Why?
|
Multifactorial Inheritance | 1 | 2017 | 1425 | 0.320 |
Why?
|
Acute Coronary Syndrome | 2 | 2019 | 2184 | 0.310 |
Why?
|
Mortality | 2 | 2021 | 2904 | 0.300 |
Why?
|
Area Under Curve | 4 | 2021 | 1638 | 0.300 |
Why?
|
Ankle Joint | 1 | 2012 | 450 | 0.300 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2018 | 1892 | 0.300 |
Why?
|
Artificial Intelligence | 2 | 2022 | 2659 | 0.300 |
Why?
|
Adolescent | 23 | 2024 | 88832 | 0.300 |
Why?
|
Schizophrenic Psychology | 1 | 2015 | 1648 | 0.290 |
Why?
|
Phenotype | 4 | 2024 | 16721 | 0.290 |
Why?
|
North Carolina | 8 | 2025 | 329 | 0.280 |
Why?
|
Leg | 1 | 2012 | 1080 | 0.280 |
Why?
|
Hospice Care | 1 | 2014 | 678 | 0.280 |
Why?
|
Postpartum Hemorrhage | 2 | 2021 | 276 | 0.280 |
Why?
|
Labor Stage, Second | 2 | 2024 | 45 | 0.270 |
Why?
|
Aged, 80 and over | 25 | 2024 | 59488 | 0.270 |
Why?
|
Body Dysmorphic Disorders | 2 | 2022 | 242 | 0.270 |
Why?
|
Myocardial Ischemia | 1 | 2017 | 2128 | 0.270 |
Why?
|
Osteoarthritis | 1 | 2015 | 1051 | 0.270 |
Why?
|
Cognition | 5 | 2022 | 7048 | 0.270 |
Why?
|
Pregnancy Complications | 3 | 2024 | 2971 | 0.270 |
Why?
|
Pregnancy | 15 | 2024 | 30258 | 0.260 |
Why?
|
Cause of Death | 2 | 2016 | 3708 | 0.260 |
Why?
|
Frail Elderly | 4 | 2022 | 785 | 0.260 |
Why?
|
Anxiety Disorders | 1 | 2017 | 2736 | 0.260 |
Why?
|
New England | 3 | 2018 | 1059 | 0.260 |
Why?
|
Genetic Variation | 2 | 2018 | 6610 | 0.250 |
Why?
|
Respiration, Artificial | 3 | 2022 | 2709 | 0.250 |
Why?
|
Seizures | 5 | 2021 | 3000 | 0.250 |
Why?
|
Language | 3 | 2025 | 1550 | 0.250 |
Why?
|
Osteogenesis, Distraction | 3 | 2012 | 232 | 0.250 |
Why?
|
Mothers | 1 | 2016 | 2208 | 0.250 |
Why?
|
Safety Management | 2 | 2021 | 763 | 0.250 |
Why?
|
Workplace | 2 | 2021 | 873 | 0.240 |
Why?
|
Dementia | 1 | 2020 | 2744 | 0.240 |
Why?
|
ROC Curve | 6 | 2024 | 3620 | 0.240 |
Why?
|
Personality Disorders | 2 | 2020 | 727 | 0.240 |
Why?
|
Carrier Proteins | 1 | 2018 | 4913 | 0.240 |
Why?
|
Treatment Outcome | 24 | 2024 | 65189 | 0.230 |
Why?
|
Borderline Personality Disorder | 2 | 2022 | 768 | 0.230 |
Why?
|
National Institute of Mental Health (U.S.) | 1 | 2024 | 107 | 0.230 |
Why?
|
Social Support | 1 | 2014 | 2192 | 0.220 |
Why?
|
Risk Factors | 21 | 2024 | 74836 | 0.220 |
Why?
|
Risk-Taking | 5 | 2017 | 1021 | 0.220 |
Why?
|
Apgar Score | 1 | 2024 | 124 | 0.220 |
Why?
|
Emotions | 1 | 2015 | 2763 | 0.210 |
Why?
|
Universities | 4 | 2009 | 998 | 0.210 |
Why?
|
Lorazepam | 1 | 2024 | 155 | 0.210 |
Why?
|
Disease Progression | 2 | 2020 | 13631 | 0.210 |
Why?
|
Alcoholic Intoxication | 3 | 2009 | 170 | 0.210 |
Why?
|
Child | 11 | 2024 | 80563 | 0.200 |
Why?
|
Clinical Coding | 1 | 2024 | 190 | 0.200 |
Why?
|
Orthopedic Procedures | 1 | 2012 | 1280 | 0.200 |
Why?
|
External Fixators | 2 | 2012 | 99 | 0.190 |
Why?
|
Communication | 1 | 2016 | 3916 | 0.190 |
Why?
|
Health Personnel | 3 | 2020 | 3390 | 0.190 |
Why?
|
Mental Fatigue | 1 | 2021 | 23 | 0.190 |
Why?
|
Life Support Care | 1 | 2023 | 226 | 0.190 |
Why?
|
Labor, Obstetric | 2 | 2021 | 316 | 0.190 |
Why?
|
Angiotensins | 1 | 2021 | 139 | 0.180 |
Why?
|
Vermont | 1 | 2020 | 80 | 0.180 |
Why?
|
Cross-Sectional Studies | 12 | 2022 | 26313 | 0.180 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2024 | 499 | 0.180 |
Why?
|
Patients' Rooms | 1 | 2021 | 63 | 0.180 |
Why?
|
Illinois | 1 | 2020 | 120 | 0.180 |
Why?
|
Comorbidity | 8 | 2024 | 10563 | 0.170 |
Why?
|
Surgery Department, Hospital | 1 | 2021 | 170 | 0.170 |
Why?
|
Cholinergic Antagonists | 1 | 2021 | 165 | 0.170 |
Why?
|
Pregnancy Trimester, Third | 1 | 2023 | 587 | 0.170 |
Why?
|
Labor, Induced | 1 | 2021 | 153 | 0.170 |
Why?
|
Pregnancy Trimester, Second | 1 | 2023 | 738 | 0.170 |
Why?
|
Bone Neoplasms | 1 | 2012 | 2567 | 0.170 |
Why?
|
Internal Medicine | 2 | 2017 | 1064 | 0.170 |
Why?
|
Bipolar Disorder | 3 | 2021 | 5128 | 0.160 |
Why?
|
Patient Care Team | 2 | 2021 | 2517 | 0.160 |
Why?
|
Genotype | 3 | 2019 | 13024 | 0.160 |
Why?
|
Intention | 1 | 2022 | 346 | 0.160 |
Why?
|
Nursing Care | 1 | 2019 | 68 | 0.160 |
Why?
|
Resilience, Psychological | 2 | 2017 | 806 | 0.160 |
Why?
|
Self-Assessment | 1 | 2021 | 400 | 0.160 |
Why?
|
Students | 4 | 2009 | 1734 | 0.150 |
Why?
|
SEER Program | 1 | 2024 | 1446 | 0.150 |
Why?
|
Critical Illness | 2 | 2022 | 2744 | 0.150 |
Why?
|
Workload | 1 | 2024 | 851 | 0.150 |
Why?
|
Prescriptions | 1 | 2021 | 388 | 0.150 |
Why?
|
Young Adult | 15 | 2024 | 59886 | 0.150 |
Why?
|
Burnout, Professional | 2 | 2017 | 710 | 0.150 |
Why?
|
Delivery of Health Care | 1 | 2016 | 5369 | 0.150 |
Why?
|
Psychomotor Agitation | 1 | 2020 | 304 | 0.150 |
Why?
|
Risk | 3 | 2019 | 9591 | 0.150 |
Why?
|
Vaccination | 3 | 2025 | 3426 | 0.140 |
Why?
|
Aerosols | 1 | 2020 | 633 | 0.140 |
Why?
|
Quality of Life | 5 | 2024 | 13461 | 0.140 |
Why?
|
Mandatory Reporting | 1 | 2018 | 123 | 0.140 |
Why?
|
Heart Failure | 2 | 2022 | 11840 | 0.140 |
Why?
|
Prevalence | 5 | 2018 | 15839 | 0.140 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2023 | 532 | 0.140 |
Why?
|
Child, Preschool | 4 | 2024 | 42500 | 0.140 |
Why?
|
Organizational Culture | 1 | 2021 | 514 | 0.140 |
Why?
|
Physicians | 4 | 2021 | 4588 | 0.140 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2020 | 418 | 0.140 |
Why?
|
Insurance Claim Reporting | 1 | 2017 | 166 | 0.130 |
Why?
|
California | 1 | 2020 | 1436 | 0.130 |
Why?
|
Radiosurgery | 3 | 2012 | 1328 | 0.130 |
Why?
|
Clostridium Infections | 1 | 2023 | 564 | 0.130 |
Why?
|
Anesthetics | 1 | 2021 | 525 | 0.130 |
Why?
|
Antimanic Agents | 1 | 2019 | 523 | 0.120 |
Why?
|
Suicidal Ideation | 2 | 2023 | 1461 | 0.120 |
Why?
|
Current Procedural Terminology | 1 | 2016 | 100 | 0.120 |
Why?
|
Delivery, Obstetric | 4 | 2024 | 946 | 0.120 |
Why?
|
Infant | 4 | 2024 | 36385 | 0.120 |
Why?
|
Occupational Health | 1 | 2021 | 813 | 0.120 |
Why?
|
Attitude | 1 | 2020 | 770 | 0.120 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2021 | 1061 | 0.120 |
Why?
|
Clinical Protocols | 1 | 2020 | 1441 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 5 | 2017 | 6499 | 0.110 |
Why?
|
Time Factors | 8 | 2023 | 40065 | 0.110 |
Why?
|
Follow-Up Studies | 12 | 2019 | 39194 | 0.110 |
Why?
|
Self Report | 5 | 2023 | 3771 | 0.110 |
Why?
|
Education, Continuing | 1 | 2015 | 115 | 0.110 |
Why?
|
Longitudinal Studies | 5 | 2024 | 14749 | 0.110 |
Why?
|
Teaching | 1 | 2021 | 1169 | 0.110 |
Why?
|
Insurance | 1 | 2015 | 115 | 0.110 |
Why?
|
Internship and Residency | 3 | 2020 | 5946 | 0.110 |
Why?
|
Brain Diseases | 1 | 2022 | 1546 | 0.110 |
Why?
|
Health Promotion | 2 | 2016 | 2208 | 0.110 |
Why?
|
Probability | 1 | 2018 | 2475 | 0.110 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2024 | 3537 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3100 | 0.100 |
Why?
|
Drug Prescriptions | 1 | 2022 | 1662 | 0.100 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2020 | 1002 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3223 | 0.100 |
Why?
|
Pre-Eclampsia | 1 | 2022 | 1261 | 0.100 |
Why?
|
Occupational Diseases | 1 | 2020 | 1456 | 0.100 |
Why?
|
Neoadjuvant Therapy | 1 | 2024 | 2895 | 0.100 |
Why?
|
Hip Prosthesis | 2 | 1989 | 895 | 0.100 |
Why?
|
Appendiceal Neoplasms | 1 | 2014 | 155 | 0.100 |
Why?
|
Delayed Diagnosis | 1 | 2016 | 452 | 0.100 |
Why?
|
Mother-Child Relations | 1 | 2016 | 499 | 0.100 |
Why?
|
Infant, Newborn | 5 | 2024 | 26349 | 0.100 |
Why?
|
Lithium | 1 | 2015 | 597 | 0.100 |
Why?
|
Angiogenesis Inhibitors | 2 | 2014 | 2056 | 0.100 |
Why?
|
Osteotomy | 2 | 2020 | 833 | 0.100 |
Why?
|
Leadership | 1 | 2021 | 1392 | 0.100 |
Why?
|
Feasibility Studies | 2 | 2024 | 5302 | 0.100 |
Why?
|
Disease | 1 | 2017 | 676 | 0.100 |
Why?
|
Substance-Related Disorders | 2 | 2019 | 4415 | 0.100 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2021 | 6014 | 0.100 |
Why?
|
Principal Component Analysis | 1 | 2015 | 951 | 0.090 |
Why?
|
Intensive Care Units | 2 | 2022 | 3800 | 0.090 |
Why?
|
Severity of Illness Index | 5 | 2024 | 15880 | 0.090 |
Why?
|
Medical Records | 1 | 2016 | 1409 | 0.090 |
Why?
|
Trigeminal Neuralgia | 1 | 2012 | 108 | 0.090 |
Why?
|
Models, Psychological | 1 | 2015 | 824 | 0.090 |
Why?
|
Data Collection | 1 | 2020 | 3318 | 0.090 |
Why?
|
Hyperthermia, Induced | 1 | 2014 | 415 | 0.090 |
Why?
|
Organ Transplantation | 1 | 2021 | 1174 | 0.090 |
Why?
|
Europe | 1 | 2017 | 3423 | 0.090 |
Why?
|
Critical Care | 1 | 2023 | 2712 | 0.090 |
Why?
|
Humerus | 1 | 2012 | 272 | 0.090 |
Why?
|
Recurrence | 2 | 2023 | 8501 | 0.090 |
Why?
|
Pilot Projects | 3 | 2019 | 8733 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2268 | 0.090 |
Why?
|
Oxidation-Reduction | 1 | 2016 | 2218 | 0.080 |
Why?
|
Angiotensin I | 1 | 2009 | 47 | 0.080 |
Why?
|
New York City | 1 | 2012 | 733 | 0.080 |
Why?
|
Reproducibility of Results | 5 | 2022 | 20125 | 0.080 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2015 | 1333 | 0.080 |
Why?
|
Renal Insufficiency | 1 | 2015 | 804 | 0.080 |
Why?
|
AIDS Serodiagnosis | 1 | 2011 | 220 | 0.080 |
Why?
|
Pregnancy Outcome | 4 | 2024 | 2967 | 0.080 |
Why?
|
Information Storage and Retrieval | 1 | 2015 | 834 | 0.080 |
Why?
|
Geriatric Assessment | 1 | 2017 | 1429 | 0.080 |
Why?
|
Anesthesia | 1 | 2020 | 1590 | 0.080 |
Why?
|
Thalidomide | 1 | 2014 | 886 | 0.080 |
Why?
|
Southeastern United States | 2 | 2021 | 94 | 0.080 |
Why?
|
Community-Based Participatory Research | 1 | 2011 | 224 | 0.080 |
Why?
|
Research Design | 3 | 2024 | 6208 | 0.080 |
Why?
|
Exercise | 2 | 2018 | 5937 | 0.080 |
Why?
|
Choroid Neoplasms | 1 | 2010 | 175 | 0.080 |
Why?
|
Parity | 2 | 2023 | 931 | 0.080 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1275 | 0.080 |
Why?
|
Alcoholism | 1 | 2019 | 1975 | 0.080 |
Why?
|
Bone Diseases | 1 | 2012 | 411 | 0.080 |
Why?
|
Sleep | 1 | 2024 | 4812 | 0.080 |
Why?
|
Wounds and Injuries | 2 | 2014 | 2511 | 0.070 |
Why?
|
Peritoneal Neoplasms | 1 | 2014 | 703 | 0.070 |
Why?
|
Prospective Studies | 6 | 2024 | 54806 | 0.070 |
Why?
|
Cluster Analysis | 1 | 2015 | 2720 | 0.070 |
Why?
|
Adolescent Behavior | 1 | 2016 | 1185 | 0.070 |
Why?
|
Medication Adherence | 1 | 2019 | 2190 | 0.070 |
Why?
|
Walking | 1 | 2015 | 1198 | 0.070 |
Why?
|
Survival Analysis | 2 | 2019 | 10070 | 0.070 |
Why?
|
Recreation | 1 | 2008 | 125 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2024 | 4900 | 0.070 |
Why?
|
Regression Analysis | 1 | 2016 | 6321 | 0.070 |
Why?
|
Prognosis | 6 | 2023 | 29921 | 0.070 |
Why?
|
Tibia | 1 | 2012 | 1062 | 0.070 |
Why?
|
Clinical Competence | 2 | 2019 | 4863 | 0.070 |
Why?
|
Emergency Service, Hospital | 2 | 2024 | 7875 | 0.070 |
Why?
|
Models, Biological | 2 | 2021 | 9443 | 0.070 |
Why?
|
Age Factors | 2 | 2020 | 18380 | 0.070 |
Why?
|
Pandemics | 3 | 2022 | 8701 | 0.070 |
Why?
|
Social Environment | 2 | 2009 | 1011 | 0.070 |
Why?
|
Cost of Illness | 1 | 2016 | 1950 | 0.070 |
Why?
|
Iodine Radioisotopes | 1 | 2010 | 1029 | 0.060 |
Why?
|
Insurance, Health | 1 | 2018 | 2520 | 0.060 |
Why?
|
Antipsychotic Agents | 1 | 2019 | 3074 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14652 | 0.060 |
Why?
|
Anxiety | 1 | 2020 | 4668 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2017 | 3564 | 0.060 |
Why?
|
Lymphedema | 1 | 2011 | 525 | 0.060 |
Why?
|
Neuropsychological Tests | 1 | 2018 | 7122 | 0.060 |
Why?
|
Glomerular Filtration Rate | 2 | 2015 | 2233 | 0.060 |
Why?
|
Opioid-Related Disorders | 1 | 2019 | 2178 | 0.060 |
Why?
|
Models, Nursing | 1 | 2024 | 46 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2014 | 2003 | 0.060 |
Why?
|
Cardiotocography | 1 | 2024 | 33 | 0.060 |
Why?
|
Gestational Age | 2 | 2024 | 3613 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2022 | 22222 | 0.060 |
Why?
|
Hypertension | 2 | 2022 | 8626 | 0.060 |
Why?
|
Curriculum | 1 | 2017 | 3782 | 0.060 |
Why?
|
Family | 1 | 2015 | 3209 | 0.060 |
Why?
|
International Classification of Diseases | 2 | 2020 | 935 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3835 | 0.050 |
Why?
|
Health Care Costs | 1 | 2017 | 3242 | 0.050 |
Why?
|
Vascular Neoplasms | 1 | 2005 | 167 | 0.050 |
Why?
|
Peer Group | 1 | 2009 | 701 | 0.050 |
Why?
|
Mastectomy | 1 | 2011 | 1847 | 0.050 |
Why?
|
Football | 1 | 2009 | 504 | 0.050 |
Why?
|
Incidence | 1 | 2021 | 21480 | 0.050 |
Why?
|
Homosexuality, Male | 1 | 2011 | 1342 | 0.050 |
Why?
|
Pregnancy Rate | 1 | 2005 | 655 | 0.050 |
Why?
|
Brachytherapy | 1 | 2010 | 1222 | 0.050 |
Why?
|
Obstetric Labor Complications | 1 | 2024 | 240 | 0.050 |
Why?
|
Hospitals, Psychiatric | 1 | 2023 | 317 | 0.050 |
Why?
|
Vena Cava, Inferior | 1 | 2005 | 463 | 0.050 |
Why?
|
Obesity | 1 | 2024 | 13075 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12509 | 0.050 |
Why?
|
Telemedicine | 1 | 2019 | 3105 | 0.050 |
Why?
|
Thiopental | 1 | 2021 | 55 | 0.050 |
Why?
|
Catheter-Related Infections | 1 | 2024 | 279 | 0.050 |
Why?
|
Depression | 4 | 2024 | 8230 | 0.050 |
Why?
|
Leiomyosarcoma | 1 | 2005 | 423 | 0.050 |
Why?
|
Ethicists | 1 | 2021 | 39 | 0.040 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2005 | 504 | 0.040 |
Why?
|
Cardiopulmonary Bypass | 1 | 2006 | 1090 | 0.040 |
Why?
|
Hydro-Lyases | 1 | 2020 | 93 | 0.040 |
Why?
|
Blood Urea Nitrogen | 1 | 2020 | 189 | 0.040 |
Why?
|
Maintenance | 1 | 2020 | 25 | 0.040 |
Why?
|
Waist Circumference | 1 | 2024 | 933 | 0.040 |
Why?
|
Erythrocyte Count | 1 | 2020 | 158 | 0.040 |
Why?
|
Actigraphy | 1 | 2024 | 531 | 0.040 |
Why?
|
Atherosclerosis | 2 | 2006 | 3425 | 0.040 |
Why?
|
Adolescent Psychiatry | 1 | 2021 | 166 | 0.040 |
Why?
|
Algorithms | 2 | 2021 | 14071 | 0.040 |
Why?
|
Aorta, Thoracic | 1 | 2006 | 1103 | 0.040 |
Why?
|
Biological Transport | 1 | 2024 | 2081 | 0.040 |
Why?
|
Postoperative Complications | 2 | 2012 | 15747 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 16047 | 0.040 |
Why?
|
Paroxetine | 1 | 2020 | 180 | 0.040 |
Why?
|
Disease-Free Survival | 4 | 2014 | 6832 | 0.040 |
Why?
|
Withholding Treatment | 1 | 2023 | 621 | 0.040 |
Why?
|
Eligibility Determination | 1 | 2022 | 423 | 0.040 |
Why?
|
Infant, Newborn, Diseases | 1 | 2024 | 587 | 0.040 |
Why?
|
Resuscitation Orders | 1 | 2020 | 275 | 0.040 |
Why?
|
Lower Extremity | 1 | 2006 | 1226 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 2020 | 790 | 0.040 |
Why?
|
Anesthetics, Intravenous | 1 | 2021 | 397 | 0.040 |
Why?
|
Emigrants and Immigrants | 1 | 2025 | 549 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2008 | 2098 | 0.040 |
Why?
|
Platelet Count | 1 | 2020 | 782 | 0.040 |
Why?
|
Brain Neoplasms | 2 | 2010 | 9071 | 0.040 |
Why?
|
Parturition | 1 | 2021 | 453 | 0.040 |
Why?
|
Infant, Low Birth Weight | 1 | 2022 | 871 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2009 | 5125 | 0.030 |
Why?
|
HIV Infections | 2 | 2016 | 17533 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2014 | 6364 | 0.030 |
Why?
|
Neoplasm Staging | 3 | 2024 | 11206 | 0.030 |
Why?
|
Policy | 1 | 2020 | 511 | 0.030 |
Why?
|
Education, Medical, Graduate | 2 | 2020 | 2418 | 0.030 |
Why?
|
Hydrocortisone | 1 | 2024 | 1827 | 0.030 |
Why?
|
Mass Screening | 2 | 2016 | 5445 | 0.030 |
Why?
|
Morphine | 1 | 2020 | 660 | 0.030 |
Why?
|
Eosinophils | 1 | 2020 | 945 | 0.030 |
Why?
|
Electroencephalography | 2 | 2021 | 6273 | 0.030 |
Why?
|
Troponin T | 1 | 2020 | 785 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2022 | 856 | 0.030 |
Why?
|
Prenatal Care | 1 | 2023 | 1159 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 747 | 0.030 |
Why?
|
Fatigue | 1 | 2022 | 1549 | 0.030 |
Why?
|
Alcohol Drinking | 1 | 2008 | 4040 | 0.030 |
Why?
|
Creatinine | 1 | 2020 | 1915 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2014 | 6942 | 0.030 |
Why?
|
Body Mass Index | 2 | 2024 | 13039 | 0.030 |
Why?
|
Infusions, Parenteral | 1 | 2014 | 395 | 0.030 |
Why?
|
Remission Induction | 1 | 2020 | 2411 | 0.030 |
Why?
|
Medicare | 2 | 2024 | 6823 | 0.030 |
Why?
|
Medically Uninsured | 1 | 2019 | 838 | 0.030 |
Why?
|
Prenatal Diagnosis | 1 | 2021 | 1270 | 0.030 |
Why?
|
Body Weight | 1 | 2024 | 4622 | 0.030 |
Why?
|
Radiotherapy Dosage | 2 | 2010 | 2865 | 0.030 |
Why?
|
Patient Education as Topic | 2 | 2015 | 2334 | 0.030 |
Why?
|
Energy Metabolism | 1 | 2024 | 2892 | 0.030 |
Why?
|
Prosthesis Failure | 2 | 1989 | 1191 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2354 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2010 | 1776 | 0.030 |
Why?
|
Heart Diseases | 1 | 2006 | 2821 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2022 | 10383 | 0.030 |
Why?
|
Smoking | 1 | 2009 | 9081 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2019 | 1406 | 0.020 |
Why?
|
Monitoring, Ambulatory | 1 | 2015 | 357 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2014 | 13648 | 0.020 |
Why?
|
Nausea | 1 | 2014 | 680 | 0.020 |
Why?
|
Melanoma | 1 | 2010 | 5719 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2020 | 6069 | 0.020 |
Why?
|
Vomiting | 1 | 2014 | 647 | 0.020 |
Why?
|
Monocytes | 1 | 2020 | 2595 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2015 | 12240 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2024 | 3925 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2008 | 7478 | 0.020 |
Why?
|
Eye Enucleation | 1 | 2010 | 128 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2010 | 6203 | 0.020 |
Why?
|
Self Care | 1 | 2015 | 800 | 0.020 |
Why?
|
Decision Making | 1 | 2023 | 3965 | 0.020 |
Why?
|
Neoplasms | 2 | 2009 | 22340 | 0.020 |
Why?
|
Amikacin | 1 | 2008 | 48 | 0.020 |
Why?
|
Bisexuality | 1 | 2011 | 295 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2024 | 4533 | 0.020 |
Why?
|
Tobramycin | 1 | 2008 | 65 | 0.020 |
Why?
|
Odds Ratio | 2 | 2014 | 9649 | 0.020 |
Why?
|
Glucose | 1 | 2020 | 4335 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3850 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2006 | 9373 | 0.020 |
Why?
|
Physical Therapy Modalities | 1 | 2011 | 533 | 0.020 |
Why?
|
Body Surface Area | 1 | 2008 | 206 | 0.020 |
Why?
|
Thromboembolism | 1 | 2014 | 1003 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2011 | 1588 | 0.020 |
Why?
|
Gentamicins | 1 | 2008 | 244 | 0.020 |
Why?
|
Cultural Competency | 1 | 2011 | 303 | 0.020 |
Why?
|
Neutrophils | 1 | 2020 | 3776 | 0.020 |
Why?
|
Health Surveys | 2 | 2009 | 4056 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2009 | 10729 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2009 | 999 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2019 | 3615 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1989 | 1600 | 0.020 |
Why?
|
Periodicity | 1 | 2008 | 345 | 0.020 |
Why?
|
New York | 1 | 1989 | 880 | 0.020 |
Why?
|
Locomotion | 1 | 1988 | 384 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2012 | 12057 | 0.020 |
Why?
|
Linear Models | 1 | 2015 | 5876 | 0.020 |
Why?
|
Retreatment | 1 | 2006 | 598 | 0.010 |
Why?
|
Quality Improvement | 1 | 2020 | 3853 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2011 | 21056 | 0.010 |
Why?
|
Birth Rate | 1 | 2005 | 169 | 0.010 |
Why?
|
Tumor Burden | 1 | 2010 | 1885 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 2014 | 1660 | 0.010 |
Why?
|
Brain | 1 | 2010 | 27178 | 0.010 |
Why?
|
Radiation Dosage | 1 | 2012 | 1944 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3432 | 0.010 |
Why?
|
Automobile Driving | 1 | 2008 | 441 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8529 | 0.010 |
Why?
|
Minority Groups | 1 | 2009 | 1207 | 0.010 |
Why?
|
Sex Offenses | 1 | 2006 | 356 | 0.010 |
Why?
|
Hip Joint | 1 | 1988 | 1000 | 0.010 |
Why?
|
Embryo Transfer | 1 | 2005 | 525 | 0.010 |
Why?
|
Patient Compliance | 1 | 2011 | 2692 | 0.010 |
Why?
|
Movement | 1 | 1988 | 1462 | 0.010 |
Why?
|
Prosthesis Design | 1 | 1988 | 2105 | 0.010 |
Why?
|
Sex Distribution | 1 | 2006 | 2263 | 0.010 |
Why?
|
Postoperative Period | 1 | 2006 | 1816 | 0.010 |
Why?
|
Treatment Failure | 1 | 2006 | 2652 | 0.010 |
Why?
|
Interpersonal Relations | 1 | 2008 | 1432 | 0.010 |
Why?
|
Visual Acuity | 1 | 2010 | 2708 | 0.010 |
Why?
|
Causality | 1 | 2006 | 1248 | 0.010 |
Why?
|
Age Distribution | 1 | 2005 | 2858 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2009 | 2115 | 0.010 |
Why?
|
Dyslipidemias | 1 | 2006 | 869 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 1988 | 2415 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2686 | 0.010 |
Why?
|
Reoperation | 1 | 1988 | 4294 | 0.010 |
Why?
|
Peptides | 1 | 2009 | 4331 | 0.010 |
Why?
|
Radiography | 1 | 1988 | 6919 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2015 | 5891 | 0.010 |
Why?
|
Survival Rate | 1 | 2010 | 12795 | 0.010 |
Why?
|
Vascular Surgical Procedures | 1 | 2005 | 1485 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2016 | 11501 | 0.010 |
Why?
|
Sex Factors | 1 | 2009 | 10602 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15398 | 0.010 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2005 | 1434 | 0.010 |
Why?
|
Pain | 1 | 1988 | 5077 | 0.010 |
Why?
|
Cardiac Surgical Procedures | 1 | 2006 | 3675 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 36532 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 2006 | 15651 | 0.000 |
Why?
|